Abstract
Xylitol is a sugar alcohol, normally produced by mammal metabolism, which has a great (and increasing) applicability in food and pharmaceutical industries due to its intriguing and proper characteristics. The most explored area is oral health, due to its non- and anti-cariogenic properties, followed by its use as a sweetener. Moreover, some other applicabilities in the medical area can be found in literature and patents, such as the use in the treatment and/or prevention of acute otitis media, respiratory diseases, parenteral nutrition, atopic dermatitis, wound repairing, gastrointestinal infections, osteoporosis, anti-aging and inflammatory processes. Market usage of xylitol for over 20 years, accompanied by toxicological studies, corroborated its safety for medical purposes. A great number of recent studies demonstrate that xylitol can be used to develop pharmaceutical products. Especially because of its activity against microorganisms, xylitol medical applications are still an important point for studies, with potential for novel medical applications in the upcoming years.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ackermann MR, Gallup JM, Zabner J, Evans RB, Brockus CW, Meyerholz DK, Grubor B, Brodgen KA (2004) Differential expression of sheep beta-defensin-1 and -2 and interleukin 8 during acute Mannheimia haemolytica pneumonia. Microb Pathog 37:21–27
Amaechi BT, Higham SM, Edgar WM (1998) The influence of xylitol and fluoride on dental erosion in vitro. Arch Oral Biol 43:157–161
Ammons MC, Ward LS, Fisher ST, Wolcott RD, James GA (2009) In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol. Int J Antimicrob Agents 33:230–236
Ammons MC, Ward LS, James GA (2011) Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings. Int Wound J 8:268–273
Amo K, Arai H, Uebanso T, Fukaya M, Koganei M, Sasaki H, Yamamoto H, Taketani Y, Takeda E (2011) Effects of xylitol on metabolic parameters and visceral fat accumulation. J Clin Biochem Nutr 49:1–7
Azarpazhooh A, Limeback H, Lawrence HP, Shah PS (2011) Xylitol for preventing acute otitis media in children up to 12 years of age. Cochrane Database Syst Rev 11:CD007095. doi:10.1002/14651858
Bader JD, Shugars DA, Vollmer WM, Gullion CM, Gilbert GH, Amaechi BT, Brown JP (2010) Design of the xylitol for adult caries trial (X-ACT). BMC Oral Health 10:22–29
Bruggeman JP, Bettinger CJ, Langer R (2010) Biodegradable xylitol based elastomers: in vivo behavior and biocompatibility. J Biomed Mater Res A 95:92–104
Calorie Control Council (2005) Reduced-calorie sweeteners: xylitol. http://www.caloriecontrol.org/xylitol.html. Accessed 05 Oct 2005
Campus G, Cagetti MG, Sacco G, Solinas G, Mastroberardino S, Lingström P (2009) Six months of daily high-dose xylitol in high-risk schoolchildren: a randomized clinical trial on plaque pH and salivary mutans streptococci. Caries Res 43:455–461
Campus G, Cagetti MG, Cocco F, Sale S, Sacco G, Strohmenger L, Lingström P (2011) Effect of sugar-free chewing gum containing Magnolia bark extract on different variables related to caries and gingivitis: a randomized controlled intervention trial. Caries Res 45:393–399
Danhauer JL, Johnson CE, Corbin NE, Broccheri KG (2010) Xylitol as a prophylaxis for acute otitis media: systematic review. Int J Audiol 49:754–761
Domenico RD, Lavecchia R (2002) Stabilization of human haemoglobin by naturally occurring osmolytes. Biochem Eng J 10:27–30
Durairaj L, Launspach J, Watt JL, Businga TR, Kline JN, Thorne PS, Zabner J (2004) Safety assessment of inhaled xylitol in mice and healthy volunteers. Respir Res 16:5–13
Durairaj L, Launspach J, Watt JL, Mohamad Z, Kline J, Zabner J (2007) Safety assessment of inhaled xylitol in subjects with cystic fibrosis. J Cyst Fibros 6:31–34
Ferreira AS, de Souza M, Barbosa NR, da Silva SS (2008) Leishmania amazonensis: xylitol as inhibitor of macrophage infection and stimulator of macrophage nitric oxide production. Exp Parasitol 119:74–79
Ferreira AS, Barbosa NR, Rodrigues D Jr, Silva SS (2009a) In vitro mechanism of xylitol action against Staphylococcus aureus ATCC 25923. In: Mendez-Vilas A (ed) Current research topics in applied microbiology and microbial biotechnology. World Scientific Publishing Co. Pte. Ltd, Seville, pp 505–509
Ferreira AS, Barbosa NR, Silva SS (2009b) In vivo xylitol dermal irritation and phototoxicity evaluation. Lat Am J Pharm 28:192–195
Ferreira AS, Souza MA, Raposo NRB, Ferreira AP, Silva SS (2011) Xylitol inhibits J774A.1 macrophage adhesion in vitro. Braz Arch Biol Technol 54:1211–1216
Franz H, Kompa HE, Rozman T (1994) Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure. Basotherm GmbH, CA2105530, 05 March 1994
Franz H, Kompa E, Rozman T (1996) Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure. USP 5.527.831, 18 June 1996
Georgieff M, Oehmke M (1990) Hypocaloric low osmotic aqueous preparation for infusion. EP 0150053B1, 13 June 1990
Georgieff M, Pscheidl E, Moldawer LL, Bistrian BR, Blackburn GL (1991) Mechanisms of protein conservation during xylitol infusion after burn injury in rats: isotope kinetics and indirect calorimetry. Eur J Clin Invest 21:249–258
Hämäläinen MM, Mäkinen KK (1982) Metabolism of glucose, fructose and xylitol in normal and streptozotocin-diabetic rats. J Nutr 112:1369–1378
Han SJ, Jeong SY, Nam YJ, Yang KH, Lim HS, Chung J (2005) Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis. Clin Diagn Lab Immunol 12:1285–1291
Hildebrandt G, Lee I, Hodges J (2010) Oral mutans streptococci levels following use of a xylitol mouth rinse: a double-blind, randomized, controlled clinical trial. Spec Care Dentist 30:53–58
Islam MS (2011) Effects of xylitol as a sugar substitute on diabetes-related parameters in nondiabetic rats. J Med Food 14:505–511
Iwata C, Nakagaki H, Morita I, Sekiya T, Goshima M, Abe T, Isogai A, Hanali M, Kuwahara M, Tatematsu M, Robinsin C (2003) Daily use of dentifrice with and without xylitol and fluoride: effect of glucose retention in humans in vivo. Arch Oral Biol 48:389–395
Jerry JB, Alonzo HJ (2005) Nasal administration of xylitol to a non-human mammal. Patent, NZ532885, 29 September
Katsuyama M, Ichikawa H, Ogawa S, Ikezawa Z (2005a) A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci 38:197–205
Katsuyama M, Kobayashi Y, Ichikawa H, Mizuno A, Miyachi Y, Matsunaga K, Kawashima M (2005b) A novel method to control the balance of skin microflora. Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin. J Dermatol Sci 38:207–213
King NA, Craig SA, Pepper T, Blundell JE (2005) Evaluation of the independent and combined effects of xylitol and polydextrose consumed as a snack on hunger and energy intake over 10 d. Br J Nutr 93:911–915
Kontiokari T, Uhari M, Koskela M (1995) Effects of xylitol of nasopharyngeal bacteria in vitro. Antimicrob Agents Chemother 39:1820–1823
Kontiokari T, Uhari M, Koskela M (1998) Antiadhesive effects of xylitol on otopathogenic bacteria. J Antimicrob Chemother 41:563–565
Korponyai C, Koyács RK, Erös G, Dikstein S, Keméry L (2011) Antiirritant properties of polyols and aminoacids. Dermatitis 22:141–146
Kruger G (2005) Efeitos refrescantes com xylitol. Aditivos Ingred 36:26–27
Kurola P, Tapianen T, Sevander J, Kaijalainen T, Leinonen M, Uhari M, Saukkoriipo A (2011) Effects of xylitol and other carbono sources on Streptococcus pneumoniae biofilm formation and gene expression in vitro. APMIS 119:135–142
Mäkinen KK (2000) Can the pentitol-hexitol theory explain the clinical observations made with xylitol? Med Hypotheses 54:603–613
Mattila PT, Svanberg MJ, Pökkä P, Knuuttila ML (1998) Dietary xylitol protects against weakning of bone biomechanical properties in ovariectomized rats. J Nutr 128:1811–1814
Mattila P, Knuutila M, Koyanen V, Svanberg M (1999) Improved bone biomechanical properties in rats after oral xylitol administration. Calcif Tissue Int 64:340–344
Mattila PT, Pelkonen P, Knuuttila ML (2005) Effects of a long-term dietary xylitol supplementation on collagen content and fluorescence of the skin in aged rats. Gerontology 51:166–169
Merck Sharp & Dohme–Chibret Dohme (1993) Ophthalmic preparation containing an acceptable antimicrobial osmotic agent. Sharp Laboratoires Merck, FR2679773, 05 Febr 1993
Milgrom P, Ly KA, Tut OK, Mancl L, Roberts MC, Briand K, Gancio MJ (2009) Xylitol pediatric topical oral syrup to prevent dental caries: a double-blind randomized clinical trial of efficacy. Arch Pediatr Adolesc Med 163:601–607
Naaber P, Lehto E, Salminen S, Mikelsaar M (1996) Inhibition of adhesion of Clostridium difficile to Caco-2 cells. FEMS Immunol Med Microbiol 14:205–209
Nakai Y, Shinga-Ishihara C, Kaji M, Moriya K, Murakami-Yamanaka K, Takimura M (2010) Xylitol gum and maternal transmission of mutans streptococci. J Dent Res 89:56–60
Renko M, Valkonen P, Tapiainen T, Kontiokari T, Mattila P, Knuuttila M, Svanberg M, Leinonen M, Karttunen R, Uhari M (2008) Xylitol-supplemented nutrition enhances bacterial killing and prolongs survival of rats in experimental pneumococcal sepsis. BMC Microbiol 8:45–51
Sajjan U, Moreira J, Liu M, Humar A, Chaparro C, Forstner J, Keshavjee S (2004) A novel model to study bacterial adherence to the transplanted airway: inhibition of Burkholderia cepacia adherence to human airway by dextran and xylitol. J Heart Lung Transplant 23:1382–1391
Sano H, Nakashima S, Songpaisan Y, Phantumvanit P (2007) Effect of xylitol and fluoride containing toothpaste on the remineralization of human enamel in vitro. J Oral Sci 49:67–73
Sanróman MA, Domínguez H, Núnez M, Lema JM (1991) Xylitol: un alcohol com futuro. Afinidad 48:215–222
Saulo AA (2005) Sugars and sweeteners in food. Food Saf Technol 16:1–7
Sawaguchi M, Sawaguchi Y, Nakao K, Kuromaru H, Haba H (2001) Xylitol nose spray. Patent, JP2001172150, 26 June 2001
Shafer RB, Levine AS, Marlette JM, Morley JE (1987) Effects of xylitol on gastric emptying and food intake. Am J Clin Nutr 45:744–747
Silva SS, Vitolo M, Mancilha IM, Roberto IC (1994) Xilitol: um adoçante alternativo para indústria de alimentos. Alimentos e Nutrição (UNESP) 5:109–117
Silva AF, Silva SS, Oliveira MG, Raposo NRB (2010a) Inibição in vitro da aderência de enteropatógenos pelo xilitol. Rev Ciênc Médicas e Biológicas 9:42–49
Silva AF, Devito KL, Silva SS, Raposo NRB (2010b) Effects of xylitol on enamel erosion control. Arq Bras Odontol 6:3–9
Silva AF, Suzuki EY, Ferreira AS, Oliveira MG, Silva SS, Raposo NRB (2011) In vitro inhibition of adhesion of Escherichia coli strains by xylitol. Braz Arch Biol Technol 54:235–241
Souza LP, Silva AF, Calil NO, Oliveira MG, Silva SS, Raposo NRB (2011) In vitro inhibition of Pseudomonas aeruginosa adhesion by xylitol. Braz Arch Biol Technol 54:877–884
Takahashi K, Onodera K, Akiba Y (1999) Effect of dietary xylitol on growth and inflammatory responses in immune stimulated chickens. Br Poult Sci 40:552–554
Takahashi K, Mashiko T, Akiba Y (2000) Effect of dietary concentration of xylitol on growth in male broiler chicks during immunological stress. Poult Sci 79:743–747
Tamanini C, Hauly MCO (2004) Resíduos agroindustriais para produção biotecnológica de xilitol. Semina: Ciências Agrárias 25:315–330
Tapiainen T, Kontiokari T, Sammalkiyi L, Ikäheimo I, Koskela M, Uhari M (2001) Effects of xylitol on growth of Streptococcus pneumoniae in the presence of fructose and sorbitol. Antimicrob Agents Chemother 45:166–169
Tapiainen T, Sormunen R, Kaijalainen T, Kontiokari R, Ikäheimo I, Uhari M (2004) Ultrastructure of Streptococcus pneumoniae after exposure to xylitol. J Antimicrob Chemother 54:225–228
Uhari M, Kontiokari T, Koskela M, Niemelä M (1996) Xylitol chewing gum in prevention of acute otitis media: double blind randomized trial. BMJ 313:1180–1184
Uhari M, Tapiainen T, Kontiokari T (2001) Xylitol in preventing acute otitis media. Vaccine 19:144–147
Ukab WA, Sato J, Wang YM, van Eys J (1981) Xylitol mediated amelioration of acetylphenyl hydrazine-induced hemolysis in rabbits. Metabolism 30:1053–1059
Valero MA, Léon-Sanz M, Escobar I, Gomis P, de la Cámara A, Moreno JM (2011) Evaluation of nonglucose carbohydrates in parenteral nutrition for diabetic patients. Eur J Clin Nutr 55:1111–1116
Wang YM, Patterson JH, van Eys J (1971) The potential use of xylitol in glucose-6-phospahte dehydrogenase deficiency anemia. J Clin Invest 50:1421–1428
Welsh MJ, Zabner J (2004) Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections. US Patent 6.716.819 B2, 06 April 2004 (University of Iowa Research Foundation )
WHO/FAO (1997) Summary of toxicological data of certain food additives. Twenty-first report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series, Geneva, 617:124–147
Wills D, Bernard R (2006) Antipyretic preparation containing xylitol. Patent, US2006142254, 29 June 2006
Ylikahri R (1979) Metabolic and nutritional aspects of xylitol. Adv Food Res 25:159–180
Zabner J, Seiler MP, Launspach JL, Karp PH, Kearney WR, Look DC, Smith JJ, Welsh MJ (2000) The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing. Proc Natl Acad Sci U S A 97:11614–11619
Acknowledgments
The financial scholarship provided by CAPES and financial support provided by FAPESP, CNPq and FAPEMIG are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
da Silva, A.F., Ferreira, A.S., da Silva, S.S., Raposo, N.R.B. (2012). Medical Applications of Xylitol: An Appraisal. In: da Silva, S., Chandel, A. (eds) D-Xylitol. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31887-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-31887-0_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31886-3
Online ISBN: 978-3-642-31887-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)